Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06486077 · ClinicalTrials.gov registry record · NA

Metabolic Health 1: Power Line Evaluation; Effect Size Determination

A NA study of Metabolic Health, sponsored by Nature's Sunshine Products.

Completed
Registry status
NA
Development phase
17
Enrollment target
1
Study location

NCT06486077 is a NA study of Metabolic Health that has completed, run by Nature's Sunshine Products. The registered enrollment target is 17 participants, below the 50,143-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06486077, a NA study of Metabolic Health, has completed, sponsored by Nature's Sunshine Products.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

The primary goal of this study is to demonstrate the safety and tolerability of the Power Line program, an integrated, whole-food supplement system. Secondarily, it is desired to determine the effect size of this program on maintenance of markers of metabolic health, with a particular emphasis on insulin sensitivity and dyslipidemia.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Power Line Program

Study Locations (1)

Utah

  • The Hughes Center for Research and Innovation - Lehi

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2025-05-20
Est. Completion 2025-11-28
Phase NA

Sponsor

Nature's Sunshine Products

4 total trials

What the Registry Record Tells You About NCT06486077

The ClinicalTrials.gov registry entry for NCT06486077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 50,143-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The listed sponsor is Nature's Sunshine Products, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Metabolic Health appearing as the primary indexed condition, and to 1 intervention - of which Power Line Program is the first listed.

NCT06486077 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT06486077 about?

NCT06486077 is a clinical study titled "Metabolic Health 1: Power Line Evaluation; Effect Size Determination". The primary goal of this study is to demonstrate the safety and tolerability of the Power Line program, an integrated, whole-food supplement system. Secondarily, it is desired to determine the effect size of this program on maintenance of markers of metabolic health, with a particular emphasis on in...

What is the current status of trial NCT06486077?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2025-05-20. Estimated completion is 2025-11-28.

What conditions does trial NCT06486077 study?

This clinical trial studies the following conditions: Metabolic Health.

What interventions are being tested in trial NCT06486077?

The interventions under investigation include: Power Line Program (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06486077?

This trial is sponsored by Nature's Sunshine Products, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06486077 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.